There is exciting research happening at the University of Pennsylvania addressing ways to slow Multiple Sclerosis progression through precision medicine. Dan and I had the opportunity last month to interact with a lead researcher on this project.
We, along with fellow MS patient advocate and author Melissa Cook, served on a patent panel with Dr. Amit Bar-Or, MD, for the CureTalks online event Transforming Multiple Sclerosis Care Through Precision Medicine.
Dr. Bar-Or is the Melissa and Paul Anderson President’s Distinguished Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. He serves as Chief of the Division of Multiple Sclerosis and Related Disorders and Director of the Center for Neuroinflammation and Neurotherapeutics.
Along with his research team, Dr. Bar-Or is investigating how immune cells interact with and influence one another to drive or calm immune attacks. They also are looking into how these cells interact with brain cells to mediate destructive inflammation in MS.
I know, this sounds incredibly complex. But it’s research, right?
And what was so encouraging about our conversation with Dr. Bar-Or is that his explanations made his research and the potential promises it holds very easy to understand.
This is why Dan and I encourage you to take the time to watch this short presentation to learn more about this encouraging research and hear how he responded to our direct questions, such as:
• How do you see this precision medicine benefiting those of us who have been living with the disease for more than two decades?
• How or will precision medicine get us closer to a cure for Multiple Sclerosis?